<DOC>
	<DOCNO>NCT00957424</DOCNO>
	<brief_summary>RATIONALE : A study evaluate participant ' belief smokeless tobacco product nicotine replacement therapy may useful help smoker stop smoking . PURPOSE : This clinical trial study acceptability less harmful alternative cigarette .</brief_summary>
	<brief_title>Acceptability Less Harmful Alternatives Cigarettes</brief_title>
	<detailed_description>OBJECTIVES : Primary - To assess impact factual information ( fact sheet ) relative harm smokeless ( SL ) /nicotine replacement ( NR ) product participant ' belief relative harmfulness . - To assess impact try sample NR and/or SL product intention use product alternative cigarette . Secondary - To explore effect factual information regard smoke tobacco smoker ' intention use product alternative cigarette . - To assess potential barrier use NR SL product substitute cigarette . - To obtain estimate possible effect size power propose comprehensive test likely outcome use product preference cigarette ( smoked product ) . OUTLINE : Participants undergo 10-15 minute web-based survey computer Tobacco Research Laboratory ass basic demographic information ; belief relative harmfulness nicotine replacement ( NR ) smokeless ( SL ) product , include use relevant question International Tobacco Control ( ITC ) 4 country survey ; past experience NR SL product perception ; willingness try sample NR/SL product previously use , , willing , reason refusal . Participants also receive information sheet simultaneously hear audio recording . Participants complete questionnaire 2 , 3 , 4 week . Beginning 2 week study intervention , participant receive day 's supply ≤ 4 smokeless tobacco nicotine product periodically undergo breath CO saliva buccal cell sample collection . Surveys complete sample collect 3 4 week .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Liver Neoplasms</mesh_term>
	<mesh_term>Kidney Neoplasms</mesh_term>
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<mesh_term>Nicotine</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Currently smoke ≥ 10 cigarette per day Not plan quit smoke next 30 day try quit past 30 day Medically eligible receive nicotinereplacement product , base NYS Smokers Quitline eligibility criterion PATIENT CHARACTERISTICS : Not pregnant nursing Able read speak English In good general health No history heart attack stroke past 2 week No history chest pain past month No report physiciandiagnosed arrhythmia/irregular heartbeat use pacemaker No report physiciandiagnosed heart disease/coronary artery disease , uncontrolled hypertension , stomach ulcer , diabetes , depression , asthma PRIOR CONCURRENT THERAPY : No concurrent tobacco product nicotine medication No concurrent Zyban , Bupropion , Wellbutrin , Chantix , smoke cessation medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>120 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>tobacco use disorder</keyword>
	<keyword>bladder cancer</keyword>
	<keyword>cervical cancer</keyword>
	<keyword>esophageal cancer</keyword>
	<keyword>gastric cancer</keyword>
	<keyword>renal cell carcinoma</keyword>
	<keyword>adult primary liver cancer</keyword>
	<keyword>non-small cell lung cancer</keyword>
	<keyword>small cell lung cancer</keyword>
	<keyword>pancreatic cancer</keyword>
	<keyword>hypopharyngeal cancer</keyword>
	<keyword>laryngeal cancer</keyword>
	<keyword>lip oral cavity cancer</keyword>
	<keyword>nasopharyngeal cancer</keyword>
	<keyword>oropharyngeal cancer</keyword>
	<keyword>paranasal sinus nasal cavity cancer</keyword>
	<keyword>adult acute myeloid leukemia</keyword>
</DOC>